HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Financial Security Advisor Inc.

Financial Security Advisor Inc. boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 6.0% in the 1st quarter, Holdings Channel reports. The firm owned 7,530 shares of the company’s stock after buying an additional 427 shares during the quarter. HCA Healthcare accounts for approximately 0.9% of Financial Security Advisor Inc.’s portfolio, making the stock its 24th biggest position. Financial Security Advisor Inc.’s holdings in HCA Healthcare were worth $2,516,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in HCA. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its stake in shares of HCA Healthcare by 2,471.9% during the first quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 7,690 shares of the company’s stock valued at $2,565,000 after acquiring an additional 7,391 shares in the last quarter. Financial Strategies Group Inc. lifted its position in shares of HCA Healthcare by 12.8% during the first quarter. Financial Strategies Group Inc. now owns 16,289 shares of the company’s stock worth $5,357,000 after purchasing an additional 1,844 shares during the last quarter. Aviance Capital Partners LLC bought a new position in shares of HCA Healthcare during the first quarter worth about $2,543,000. LVW Advisors LLC lifted its position in shares of HCA Healthcare by 76.4% during the first quarter. LVW Advisors LLC now owns 3,189 shares of the company’s stock worth $1,064,000 after purchasing an additional 1,381 shares during the last quarter. Finally, Red Door Wealth Management LLC lifted its position in shares of HCA Healthcare by 4.6% during the first quarter. Red Door Wealth Management LLC now owns 19,868 shares of the company’s stock worth $6,627,000 after purchasing an additional 881 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $4.58 during mid-day trading on Tuesday, hitting $319.70. The company’s stock had a trading volume of 1,458,969 shares, compared to its average volume of 1,102,668. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The stock has a market capitalization of $83.73 billion, a P/E ratio of 15.99, a P/E/G ratio of 1.49 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $344.20. The stock’s fifty day moving average price is $326.06 and its two-hundred day moving average price is $317.80.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.93 earnings per share. Research analysts forecast that HCA Healthcare, Inc. will post 20.92 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.83%. The ex-dividend date was Friday, June 14th. HCA Healthcare’s payout ratio is 13.16%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now directly owns 22,365 shares in the company, valued at approximately $6,977,880. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 6,311 shares of HCA Healthcare stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the completion of the sale, the executive vice president now owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The disclosure for this sale can be found here. In the last three months, insiders have sold 12,397 shares of company stock worth $3,921,929. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Oppenheimer increased their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Cantor Fitzgerald reissued an “overweight” rating and issued a $335.00 target price on shares of HCA Healthcare in a report on Tuesday. Barclays raised their target price on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $326.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.